Stephen Henry took home the prize of Supreme Innovator award at the NZ Innovators Awards.
His company Kode Biotech have created a cancer treatment using the human body’s own auto immune responses.
The treatment involves injecting cells that mimic toxic animal tissue into tumours.
As the immune system naturally rejects animal tissue, it attacks the tumour.
In June the company signed a licensing agreement with UK company Agalimmune that could be worth up to $47 million.
Kode Biotech also took home the award for Best Innovation in Health and Science.
The head of AUT’s School of Engineering, Professor Enrico Haemmerle, says it was great to see Stephen praised in this way.
“Steve Henry is an inventor, but more importantly, an innovator who has the ability to convert ideas into commercial value. He is an ongoing inspiration to AUT students and staff, and it is great to see his important work getting the recognition it deserves. “
Watch the video for the full segment.